Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura K Hummers

Showing results (51-60 of 132) with videos related to

Pageof 14
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|December 20, 2021
Diastolic Dysfunction in Systemic Sclerosis: Risk Factors and Impact on MortalityAlicia M Hinze, Jamie Perin, Adrianne Woods, et al.
Clinical and Experimental Rheumatology|January 27, 2022
Troponin elevation independently associates with mortality in systemic sclerosisJulie J Paik, Deborah Y Choi, Monica Mukherjee, et al.
Arthritis Care & Research|January 26, 2012
Efficacy of Rho kinase inhibitor fasudil in secondary Raynaud's phenomenonAndrea Fava, Peter K Wung, Fredrick M Wigley, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 26, 2020
Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To ComplexChristopher A Mecoli, Brittany L Adler, Qingyuan Yang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 29, 2017
ReplyAmi A Shah, Antony Rosen, Laura K Hummers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 21, 2017
Brief Report: Anti-RNPC-3 Antibodies As a Marker of Cancer-Associated SclerodermaAmi A Shah, George Xu, Antony Rosen, et al.
Arthritis and Rheumatism|January 31, 2009
Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung diseaseStephen C Mathai, Laura K Hummers, Hunter C Champion, et al.
Annals of the Rheumatic Diseases|April 22, 2018
Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancerTakeru Igusa, Laura K Hummers, Kala Visvanathan, et al.
Arthritis Care & Research|August 9, 2021
Slow Colonic Transit in Systemic Sclerosis: An Objective Assessment of Risk Factors and Clinical PhenotypeJenice X Cheah, Jamie Perin, Elizabeth R Volkmann, et al.
Rheumatology (Oxford, England)|December 5, 2022
Cumulative disease damage and anti-PM/Scl antibodies are associated with a heavy burden of calcinosis in systemic sclerosisCarrie Richardson, Jamie Perin, Scott Zeger, et al.
Pageof 14

Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
Arthritis & Rheumatology (Hoboken, N.J.)|December 20, 2021
Diastolic Dysfunction in Systemic Sclerosis: Risk Factors and Impact on MortalityAlicia M Hinze, Jamie Perin, Adrianne Woods, et al.
Clinical and Experimental Rheumatology|January 27, 2022
Troponin elevation independently associates with mortality in systemic sclerosisJulie J Paik, Deborah Y Choi, Monica Mukherjee, et al.
Arthritis Care & Research|January 26, 2012
Efficacy of Rho kinase inhibitor fasudil in secondary Raynaud's phenomenonAndrea Fava, Peter K Wung, Fredrick M Wigley, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 26, 2020
Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To ComplexChristopher A Mecoli, Brittany L Adler, Qingyuan Yang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 29, 2017
ReplyAmi A Shah, Antony Rosen, Laura K Hummers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 21, 2017
Brief Report: Anti-RNPC-3 Antibodies As a Marker of Cancer-Associated SclerodermaAmi A Shah, George Xu, Antony Rosen, et al.
Arthritis and Rheumatism|January 31, 2009
Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung diseaseStephen C Mathai, Laura K Hummers, Hunter C Champion, et al.
Annals of the Rheumatic Diseases|April 22, 2018
Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancerTakeru Igusa, Laura K Hummers, Kala Visvanathan, et al.
Arthritis Care & Research|August 9, 2021
Slow Colonic Transit in Systemic Sclerosis: An Objective Assessment of Risk Factors and Clinical PhenotypeJenice X Cheah, Jamie Perin, Elizabeth R Volkmann, et al.
Rheumatology (Oxford, England)|December 5, 2022
Cumulative disease damage and anti-PM/Scl antibodies are associated with a heavy burden of calcinosis in systemic sclerosisCarrie Richardson, Jamie Perin, Scott Zeger, et al.
Pageof 14